Loading

Policy

  • by NORML August 16, 2017

    mj_researchRepresentatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017.

    This Act amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products.

    As you may know, there are many benefits to medical cannabis. Those suffering from PTSD, Tourette’s Syndrome, Parkinson’s Disease, and many other debilitating conditions have found relief because of medical marijuana.  

    But, despite the fact that over 200 million Americans now have legal access to some form of medical marijuana, present regulations make clinical investigations involving cannabis needlessly onerous. Passage of this measure would expedite federal reviews of clinical protocols, provide greater access to scientists who wish to study the drug, and mandate an FDA review of the relevant science.

    Please click HERE to contact your Representative and urge him/her to support this important measure.

     

  • by Justin Strekal, NORML Political Director August 15, 2017

    Jeff_Sessions_(29299022521)As first reported by Tom Angell of MassRoots.com, Washington State Governor Jay Inslee and Attorney General Bob Ferguson responded to a July 24 letter from US Attorney General Jeff Sessions, in which Sessions’ made multiple allegations all based on a single misleading 2016 report.

    One would say, they didn’t pull any punches:

    “Your letter, citing the March 2016 Northwest High Intensity Drug Trafficking Area (NW HIDTA) report on marijuana in Washington, makes a number of allegations that are outdated, incorrect, or based on incomplete information.”

     

    Cutting right to the heart of the matter, i.e. facts, the Washington state leaders again articulated their desire to educate the (seemingly willing) ignorant Sessions.

    “We have twice requested an in-person meeting with you because we believe it will lead to better understanding than exchanging letters. If we can engage in a more direct dialogue, we might avoid this sort of miscommunication and make progress on the issues that are important to both of us. We therefore reiterate our request to meet with you, followed by further appropriate meetings between state and DOJ officials.”

     

    One of the most basic functions of government is to simply provide consistency and certainty in law enforcement. So after repeated efforts by the state’s leadership to receive clarification, basic facets of the Department of Justice’s approach are still unknown. In yet another attempt for guidance, the Governor and state Attorney General requested information on:

    • Whether DOJ intends to follow recommendations from its Task Force on Crime Reduction and Public Safety—in particular, its reported recommendation to continue previous federal policy on state legalization of marijuana.
    • Whether President Trump’s previous statements of support for medical marijuana, and leaving recreational marijuana legalization to the states, represent the policy of the federal government.
    • Whether DOJ will support reasonable federal policies allowing financial institutions to provide service to licensed marijuana businesses, in order to avoid the public safety risks and transparency problems associated with all-cash businesses.
    • How state-regulated marijuana should be treated by the federal government following the President’s declaration that the opioid crisis constitutes a national emergency, and whether the federal government will support objective, independent research into the effects of marijuana law reform on opioid use and abuse.
    • Whether the federal government will help protect public health by supporting agricultural research on the safety of pesticides used in marijuana cultivation.
    • Whether the federal government will support research into expedited roadside DUI testing methods for law enforcement, as alternatives to blood draws.

     

    How Attorney General Sessions will respond, only time will tell.

    You can click HERE to send a message to your Representative to urge their support for The Respect State Marijuana Laws Act, bipartisan legislation to prevent the Department of Justice from enforcing federal prohibition in states that have chosen to legalize medical or adult-use marijuana.

    You can view the full letter from Governor Inslee and AG Ferguson below:

    Washington Officials Respond to Sessions Marijuana Letter by tomangell on Scribd

  • by NORML

    HumboldtOne of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by debunking marijuana myths and half-truths via the publication of timely op-eds in online and print media. Since the mainstream media seldom casts a critical eye toward many of the more over-the-top claims about cannabis, we take it upon ourselves to set the record straight.

    The majority of NORML’s rebuttals are penned by Deputy Director Paul Armentano. In the past few weeks, he has published numerous op-eds rebuking a litany of popular, but altogether specious claims about the cannabis plant – including the contentions that cannabis consumption is linked to heart attacks, psychosis, violence, and a rise in emergency room visits and traffic fatalities, among other allegations.

    Below are links to a sampling of his recent columns.:

    Blowing up the big marijuana IQ myth — The science points to zero effect on your smarts

    Blowing the lid off the ‘marijuana treatment’ racket

    The five biggest marijuana myths and how to debunk them

    It took just one distorted study for the media to freak out over health risks marijuana

    Cannabis mitigates opioid abuse — the science says so

    Three new marijuana myth-busting studies that the mainstream media isn’t picking up on

    For a broader sampling of NORML-centric columns and media hits, please visit NORML’s ‘In the Media’ archive here.

    If you see the importance of NORML’s educational and media outreach efforts, please feel free to show your support by making a contribution here.

  • by Justin Strekal, NORML Political Director August 14, 2017
    Congresswoman Suzan DelBene (D-WA-1)

    Congresswoman Suzan DelBene (D-WA-1)

    Congresswoman Suzan DelBene (D-WA-01) has reintroduced the State Marijuana And Regulatory Tolerance (SMART) Enforcement Act (H.R. 3534). This bill prohibits state-sanctioned marijuana consumers and businesses from being prosecuted by the federal government.

    By a margin of more than 6 to 1, Americans say that individual states should be able to make their own laws governing the use and sale of marijuana. The SMART Enforcement Act acknowledges this voter sentiment while also ensuring states are operating in a safe and responsible manner.

    In a prepared statement, Congresswoman DelBene says that her legislation “will fix the conflict between state and federal law by giving states effectively regulating marijuana themselves, such as Washington, a waiver from the Controlled Substances Act. It also resolves the banking issues currently forcing dispensaries to operate on an unsafe, all-cash basis. These waivers will ensure people in states that have different laws than the federal government on marijuana are protected from prosecution, provided they meet certain requirements, as more and more states work to regulate marijuana within their own borders.”

    Legislation similar to this is pending in California, Assembly Bill 1578, to try and limit potential federal interference in the state’s marijuana regulatory laws. As Congresswoman DelBene said, “People in these states should not live in fear of the unpredictable actions of the Attorney General and Department of Justice.”

    Click HERE to urge your Representatives to support this legislation.

  • by NORML August 8, 2017

    hempfieldCongressman James Comer (R-KY-1) and 15 co-sponsors have reintroduced legislation to amend the federal Controlled Substances Act to exclude industrial hemp.

    Currently, the Controlled Substances Act of 1970 labels hemp as a Schedule I drug.

    H.R. 3530 excludes low-THC strains of cannabis grown for industrial purposes from the federal definition of marijuana.

    The majority of US states have already enacted legislation redefining hemp as an agricultural commodity and allowing for its cultivation. In 2014, members of Congress approved language in the omnibus federal Farm Bill explicitly authorizing states to sponsor hemp research absent federal reclassification of the plant.

    All parts of the hemp plant can be cultivated and used to produce everyday household items. It can be grown as a renewable source for raw materials such as clothing, paper, construction materials, and biofuel. Not only is it useful, but growing hemp is much more environmentally friendly than traditional crops.

    According to the Congressional Research Service, the United States is the only developed nation in which industrial hemp is not an established crop.

    Click HERE to urge your Representative to support this legislation.

     

Page 5 of 39« First...34567...102030...Last »